



BIOPHEN™ FVIIa Control Set (Special Terms Apply*)
We're always working hard to give our customers as much information on products and the best price possible. If you need any assistance or would like a quote please contact us and we will be happy to help
BIOPHEN™ FVIIa Control Set (224901) is a set for the quality control of FVIIa assay by clotting method. Manufactured by HYPHEN BioMed.
*Special Terms: Please see product specification details below for details.
Intended Use
BIOPHEN™ FVIIa Control Set kit consists of lyophilized activated Factor VII (FVIIa) at various concentration, for the quality control of FVIIa activity measurements.
They are titrated and optimized for the assay of FVIIa by clotting technique.
Summary and Explanation
Technical These controls are proposed for the quality control of clotting assays of FVIIa (HEMOCLOT™ Factor VIIa).
Clinical Recombinant activated Factor VII (rFVIIa) may be used for treatment of patients with haemophilia and inhibitors, or in various contexts of haemorrhage.
Reagents
C1 Control 1: Lyophilized purified human FVIIa containing a titrated quantity of FVIIa of approximately 75 mIU/mL. Contains BSA.
C2 Control 2: Lyophilized purified human FVIIa containing a titrated quantity of FVIIa of approximately 250 mIU/mL. Contains BSA.
Each kit contains 3 vials of 1mL of C1 and 3 vials of 1mL of C2.
Controls contain stabilizing agents.
The control concentrations may vary slightly from one batch to another. For the assay, see the exact values indicated on the flyer provided with the kit used.
UKCA